Terms: = Gastric cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Treatment
3 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
Yu XW; Wei D; Gao YS; Du HZ; Yu BY; Li RM; Qian CM; Luo XJ; Yuan ST; Wang JS; Sun L
J Cell Mol Med; 2019 Oct; 23(10):6622-6634. PubMed ID: 31397978
[TBL] [Abstract] [Full Text] [Related]
3. Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.
Yu XW; Lin S; Du HZ; Zhao RP; Feng SY; Yu BY; Zhang LY; Li RM; Qian CM; Luo XJ; Yuan ST; Sun L
Oncotarget; 2016 May; 7(22):32990-3003. PubMed ID: 27105508
[TBL] [Abstract] [Full Text] [Related]
